Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

Pilot Study of the Navigator Continuous Glucose Monitor

NCT00166673
completednot_applicable

Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic Control

NCT01214824
completed

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

NCT00920881

Clinical Trials (3)

Showing 3 of 3 trials
NCT00166673Phase 2

Pilot Study of the Navigator Continuous Glucose Monitor

Completed
NCT01214824Not Applicable

Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic Control

Completed
NCT00920881

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3